dentalcorp — Q1 2023 Earnings Presentation
15 slides from dentalcorp's earnings presentation, May 12, 2023
Slide 1: Investor Review Q1 2023
Investor Review Q1 2023 TSX: DNTL
Slide 2: Disclaimer
Disclaimer Any graphs, tables or other information demonstrating our historical performance or that of any other entity contained in this presentation are intended only to illustrate past performance and are not necessarily indicative of such entities' future performance. Investors should not assume
Slide 3: Double-digit growth every year in our history
1 Double-digit growth every year in our history dentalcorp by the numbers Our people2 LTM performance3 1,850+ Dentists ▪ PF Revenue4 of $1.4 billion, an increase of 15% year over year 2,400+ Dental Hygienists,and 5,500+ Auxiliary Dental Health Professionals ▪ PF Adjusted EBITDA4 of $260 million, an
Slide 4: Balanced approach to driving sustained double-digit growth
Balanced approach to driving sustained double-digit growth 1 ▪ Same Practice Revenue Growth1,2 supported by expansion ORGANIC 4%+ medium-term target for Same Practice Revenue of specialty service offerings (e.g., clear aligner GROWTH Growth1,2 orthodontic treatment, implants) ▪ Generally 10-15%+ inc
Slide 5: Prudent balance sheet management remains a priority
Prudent balance sheet management remains a priority Medium-term leverage targets combined with strong liquidity position dentalcorp well to invest in growth Net Debt / PF Adjusted EBITDA after rent Ratio (x)1 4.4x <3.0x Illustrative Medium-Term ~1.5x Target Without Acquisitions Q1 20231 Medium-Term
Slide 6: First quarter 2023 highlights
First quarter 2023 highlights Highlights: • Revenue of $358.3 million, an increase of 28% over the same period in 2022 • Same Practice Revenue Growth of 8.5%, with Same Practice EBITDA Growth of 11.2% • Adjusted EBITDA from acquisitions completed in 2022(1) up 19.3% • Adjusted EBITDA(1) of $65.6 mil
Slide 7: Financial highlights
Financial highlights Three months ended Mar 3 1 Revenue 2023 2022 • Revenues for the first quarter 2023 increased to $358.3 million, up $ millions $ millions 27.9% over the first quarter 2022 due to: Revenue 358.3 280.2 • Same Practice Revenue Growth(1) of 8.5% over the first Increase / (Decrease) 2
Slide 8: Net leverage and liquidity
Net leverage and liquidity Capac ity as at Drawn As at Mar Available Debt & Liquidity Mar 3 1 , 2 0 2 3 31, 2023 • Ended the first quarter 2023 with liquidity of $785 million, comprised of $111 million in cash, and $674 million in $ millions $ millions $ millions undrawn debt capacity under the seni
Slide 9: Fiscal 2023 outlook
Fiscal 2023 outlook STRONG SAME PRACTICE REVENUE GROWTH DISCIPLINED APPROACH TO ACQUISITIONS IMPROVING MARKET CONDITIONS The Company expects strong Same The Company anticipates its disciplined With improving market conditions, Practice Revenue Growth(1) throughout the approach to acquisitions will u
Slide 10: Appendix
Appendix
Slide 11: Income statement highlights
Income statement highlights Three months ended Mar 3 1 2023 2022 $ millions $ millions Revenue 358.3 280.2 Cost of revenue 179.3 141.1 Gross profit 1 7 9 .0 1 3 9 .1 Selling, general and administrative expenses 117.2 94.4 Depreciation and amortization 51.8 41.5 Share-based compensation 4.2 5.6 Forei
Slide 12: Adjusted net income Reconciliation
Adjusted net income Reconciliation (a) Share-based compensation Non-cash expense for share-based compensation during the period. Three months ended Mar 3 1 2023 2022 (b) Change in fair value of contingent consideration $ millions $ millions On acquisition, and at each subsequent reporting date, obli
Slide 13: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation Three months ended Mar 3 1 2023 2022 (a) Share-based compensation $ millions $ millions Non-cash expense for share-based compensation during the period. Net income (loss) and comprehensive income (loss) (33.3) (11.0) Finance costs, net 23.3 11.1 (b) External acquisitio
Slide 14: Cash Flow Highlights and Adjusted Free Cash Flow Reconciliation
Cash Flow Highlights and Adjusted Free Cash Flow Reconciliation Three months ended Mar 3 1 Operating activities 2023 2022 • Cash flow from operations was strong in the first quarter due to $ millions $ millions strong same practice revenue growth(1) Adjusted Cash Flow from Operating Activities 50.0
Slide 15: LTM PF Revenue and PF Adjusted EBITDA Reconciliation
LTM PF Revenue and PF Adjusted EBITDA Reconciliation Twelve months ended Mar (a) Acquisition adjustment 31, 2023 Additional revenue and EBITDA estimated to have been earned in $ millions the period if all acquisitions in the period were completed on the LTM Revenue 1,328.3 first day of the period. A